chr17-59070887-G-A
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_015294.6(TRIM37):c.745C>T(p.Gln249*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,461,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015294.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIM37 | NM_015294.6 | c.745C>T | p.Gln249* | stop_gained | 9/24 | ENST00000262294.12 | NP_056109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIM37 | ENST00000262294.12 | c.745C>T | p.Gln249* | stop_gained | 9/24 | 1 | NM_015294.6 | ENSP00000262294.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251454Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135900
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727186
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mulibrey nanism syndrome Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The TRIM37 c.745C>T (p.Gln249Ter) variant is a stop-gained variant that is predicted to cause premature truncation of the protein. The p.Gln249Ter variant has been reported in one study in which it was found in one individual with Mulibrey nanism in a compound heterozygous state with a frameshift variant (Hamalainen et al. 2004). The p.Gln249Ter variant was absent from 95 controls and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium despite being in a region of good coverage. Due to the potential impact of stop-gained variants and supporting evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for Mulibrey nanism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 15, 2023 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 05, 2023 | This sequence change creates a premature translational stop signal (p.Gln249*) in the TRIM37 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRIM37 are known to be pathogenic (PMID: 10888877, 15108285). This variant is present in population databases (rs386834005, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with mulibrey nanism (PMID: 15108285). ClinVar contains an entry for this variant (Variation ID: 56570). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at